Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.
The lack of clinical progression in some individuals despite prolonged human immunodeficiency virus type 1 (HIV-1) infection may result from infection with less-pathogenic viral strains. To address this question, we examined the HIV-1 envelope protein from a donor with a low viral burden, stable CD4(+) T-lymphocyte counts, and little evidence of CD8(+) T-cell expansion, activation, or immune activity. To avoid potential changes in envelope function resulting from selection in vitro, envelope clones were constructed by using viral RNA isolated from uncultured peripheral blood mononuclear cells (PBMC). The data showed that recombinant viruses containing envelope sequences derived from RNA isolated from patient PBMC replicated poorly in primary CD4(+) T cells but demonstrated efficient growth in macrophages. The unusual phenotype of these viruses could not be explained solely by differential utilization of coreceptors since the chimeric viruses, as well as an uncloned isolate obtained from the same visit date, can utilize CCR5. In addition, the donor's own cells appeared resistant to infection with chimeric viruses containing autologous envelope sequences. Genotype analysis revealed that the donor was heterozygous for the previously described 32-bp deletion in CCR5 which may be linked with prolonged survival in HIV-1-infected individuals. These data suggest that the changes in envelope sequences confer properties of viral attenuation, which together with the CCR5 +/Delta32 genotype could account for the long-term survival of this patient.
Grovit-Ferbas
K
K
Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine and UCLA AIDS Institute, Los Angeles, California 90095-1678, USA.
Ferbas
J
J
Gudeman
V
V
Sadeghi
S
S
Goetz
M B
MB
Giorgi
J V
JV
Chen
I S
IS
O'Brien
W A
WA
D000595:Amino Acid Sequence; D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D015686:Gene Products, env / Q000235:genetics; D015752:Genes, env; D015658:HIV Infections / Q000235:genetics* / Q000276:immunology / Q000821:virology*; D020276:HIV Long-Term Survivors; D015497:HIV-1 / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology; D006579:Heterozygote; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008264:Macrophages / Q000821:virology; D008297:Male; D008969:Molecular Sequence Data; D010641:Phenotype; D012367:RNA, Viral / Q000097:blood / Q000235:genetics; D016865:Reassortant Viruses / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics; D011995:Recombination, Genetic; D017384:Sequence Deletion; D014774:Virulence / Q000235:genetics; D014779:Virus Replication
D015686:Gene Products, env; D012367:RNA, Viral; D019713:Receptors, CCR5